Dr. Garibaldi's 40 years of experience brings industry-leading pharmaceuticals development expertise to the Scientific Board of Advisors. His appointment demonstrates the company's resolve to leverage ...
Brian Garibaldi, JHU Biocontainment Unit Director, joins The Final Round to discuss his thoughts on the rising numbers of cases across the globe and the most recent developments in the vaccine race.
Dr. George Garibaldi, MD, named Synendos CMO · GlobeNewswire Inc. BASEL, Switzerland, July 15, 2025 (GLOBE NEWSWIRE) -- Synendos Therapeutics (“Synendos”), the clinical-stage biotechnology company ...
Synendos Therapeutics, a clinical-stage biotechnology company developing breakthrough therapies for neuropsychiatric disorders, announced that it has named Dr. George Garibaldi, company’s CMO. This ...
BALTIMORE (WJZ) -- Researchers at Johns Hopkins University released a new COVID-19 prediction model, which can forecast whether or not a patient's condition will likely improve or deteriorate. Dr.
Doctors at Johns Hopkins Hospital in Baltimore are often called on to treat top corporate executives, Supreme Court justices and even Arab royalty. In recent days, the president of the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results